Abbott Laboratories, et al.; Withdrawal of Approval of Four New Drug Applications and Two Abbreviated New Drug Applications

1 recorded connections shown. Select a record, office or person to follow its source references.

Start with

and connect to

Zoom to read. Drag to explore. Select a connection.

Federal rule or notice · As of Dec 29, 2016

Federal rule or notice

Abbott Laboratories, et al.; Withdrawal of Approval of Four New Drug Applications and Two Abbreviated New Drug Applications: 1 outgoing connections shown. Point at anyone to see how they are linked.Showing bounded source connections. Dates come from the held records; missing relationships remain unknown.

The source record

As of Dec 29, 2016; may be out of date.

Document number: 2016-31625
Document type: Notice
Title: Abbott Laboratories, et al.; Withdrawal of Approval of Four New Drug Applications and Two Abbreviated New Drug Applications
Publication date: 2016-12-29
Action: Notice.
Html url: https://www.federalregister.gov/d/2016-31625
Created at: 2026-09-24T17:39:10.955069
Updated at: 2026-09-24T17:39:10.955069

Open the official source

Every link on this map

The same connections as a table, with the reason each one is here.

Sort by

Connections of Abbott Laboratories, et al.; Withdrawal of Approval of Four New Drug Applications and Two Abbreviated New Drug Applications

Federal rule or notice	What this connects to	Abbott Laboratories, et al.; Withdrawal of Approval of Four New Drug Applications and Two Abbreviated New Drug Applications has a recorded connection to Federal rule or notice.	None